I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Real-world use of once-weekly semaglutide in patients with ..:
Rajamand Ekberg, Neda
;
Bodholdt, Ulrik
;
Catarig, Andrei Mircea
...
Rajamand Ekberg , N , Bodholdt , U , Catarig , A M , Catrina , S B , Grau , K , Holmberg , C N , Klanger , B & Knudsen , S T 2021 , ' Real-world use of once-weekly semaglutide in patients with type 2 diabetes : Results from the SURE Denmark/Sweden multicentre, prospective, observational study ' , Primary Care Diabetes , vol. 15 , no. 5 , pp. 871-878 . https://doi.org/10.1016/j.pcd.2021.06.008. , 2021
Link:
https://pure.au.dk/portal/da/publications/realworld-us..
RT Journal T1
Real-world use of once-weekly semaglutide in patients with type 2 diabetes:Results from the SURE Denmark/Sweden multicentre, prospective, observational study
UL https://suche.suub.uni-bremen.de/peid=base-ftuniaarhuspubl:oai:pure.atira.dk:publications_cffaad6f-ca2e-4382-beb1-58fadb56ffe2&Exemplar=1&LAN=DE A1 Rajamand Ekberg, Neda A1 Bodholdt, Ulrik A1 Catarig, Andrei Mircea A1 Catrina, Sergiu Bogdan A1 Grau, Katrine A1 Holmberg, Cecilia Nagorny A1 Klanger, Boris A1 Knudsen, Søren Tang YR 2021 K1 Body weight K1 Glucagon-like peptide-1 receptor agonist K1 HbA K1 Real-world evidence K1 Semaglutide K1 SURE study K1 Type 2 diabetes K1 METFORMIN K1 ADD-ON K1 EFFICACY K1 SAFETY K1 PHASE 3A K1 OPEN-LABEL K1 MELLITUS K1 56-WEEK K1 HbA(1c) K1 Prospective Studies K1 Humans K1 Diabetes Mellitus K1 Type 2/diagnosis K1 Sweden K1 Adult K1 Treatment Outcome K1 Glucagon-Like Peptides/therapeutic use K1 Denmark K1 Hypoglycemic Agents/therapeutic use K1 Glycated Hemoglobin A/analysis JF Rajamand Ekberg , N , Bodholdt , U , Catarig , A M , Catrina , S B , Grau , K , Holmberg , C N , Klanger , B & Knudsen , S T 2021 , ' Real-world use of once-weekly semaglutide in patients with type 2 diabetes : Results from the SURE Denmark/Sweden multicentre, prospective, observational study ' , Primary Care Diabetes , vol. 15 , no. 5 , pp. 871-878 . https://doi.org/10.1016/j.pcd.2021.06.008 LK http://dx.doi.org/https://pure.au.dk/portal/da/publications/realworld-use-of-onceweekly-semaglutide-in-patients-with-type-2-diabetes(cffaad6f-ca2e-4382-beb1-58fadb56ffe2).html DO https://pure.au.dk/portal/da/publications/realworld-use-of-onceweekly-semaglutide-in-patients-with-type-2-diabetes(cffaad6f-ca2e-4382-beb1-58fadb56ffe2).html SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)